PARATEK PHARMACEUTICALS INC
Action · US6993743029 · PRTK · A12EGE (XNMS)
Pas de cours
n/a
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -54,58 % |
Profil de l'entreprise pour PARATEK PHARMACEUTICALS INC Action
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. In addition, it has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Fonds investis
Les fonds suivants ont investi dans : PARATEK PHARMACEUTICALS INC investi :
Fonds | Vol. en millions 7,95 | Part (%) 0,02 % |
Données de l'entreprise
Nom PARATEK PHARMACEUTICALS INC
Société Paratek Pharmaceuticals, Inc.
Symbole PRTK
Site web
https://paratekpharma.com
Marché d'origine
NASDAQ/NMS (GLOBAL MARKET)
WKN A12EGE
ISIN US6993743029
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Evan Loh FACC, FAHA, M.D.
Capitalisation boursière 128 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,3 T
Adresse 75 Park Plaza, 02116 Boston
Date d'introduction en bourse 2009-02-03
Dividendes de 'PARATEK PHARMACEUTICALS INC'
Date ex-dividende | Dividende par action |
---|---|
31.10.2014 | 0,06 USD |
22.10.2014 | 0,67 USD |
04.06.2014 | 1,33 USD |
21.05.2014 | 1,33 USD |
Fractionnements d'actions
Date | Fractionnement |
---|---|
31.10.2014 | 1:12 |
Changements d'identifiant
Date | De | À |
---|---|---|
30.10.2014 | TSPT | PRTK |
Symboles boursiers
Nom | Symbole |
---|---|
NASDAQ | PRTK |
Autres actions
Les investisseurs qui détiennent PARATEK PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.